Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00072384 · ClinicalTrials.gov registry record · Phase 3
Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00072384 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 30 participants.
The verdict
NCT00072384, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
Phase III trial to determine the effectiveness of combining systemic chemotherapy and subtenon carboplatin with ophthalmic therapy in treating children who have intraocular retinoblastoma. Drugs used in chemotherapy, such as vincristine, carboplatin, and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether systemic chemotherapy and subtenon (under the conjunctiva of the eye) carboplatin combined with ophthalmic therapy is effective in treating intraocular (within the eyeball) retinoblastoma.
Interventions
- DRUG carboplatin
- DRUG etoposide
- PROCEDURE cryosurgery
- DRUG liposomal vincristine sulfate
- PROCEDURE laser surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-04-16 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00072384
The ClinicalTrials.gov registry entry for NCT00072384 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which carboplatin is the first listed.
NCT00072384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00072384 about?
NCT00072384 is a clinical study titled "Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma". Phase III trial to determine the effectiveness of combining systemic chemotherapy and subtenon carboplatin with ophthalmic therapy in treating children who have intraocular retinoblastoma. Drugs used in chemotherapy, such as vincristine, carboplatin, and etoposide, work in different ways to stop tum...
What is the current status of trial NCT00072384?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2007-04-16. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT00072384?
The interventions under investigation include: carboplatin (DRUG), etoposide (DRUG), cryosurgery (PROCEDURE), liposomal vincristine sulfate (DRUG), laser surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00072384?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.